North Crest Asset Manangement, LLC Kura Oncology, Inc. Transaction History
North Crest Asset Manangement, LLC
- $3.19 Billion
- Q4 2024
A detailed history of North Crest Asset Manangement, LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, North Crest Asset Manangement, LLC holds 10,687 shares of KURA stock, worth $88,488. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,687
Previous 10,687
-0.0%
Holding current value
$88,488
Previous $208,000
55.29%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding KURA
# of Institutions
196Shares Held
79.6MCall Options Held
98.7KPut Options Held
70.1K-
Black Rock Inc. New York, NY6.97MShares$57.7 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.8MShares$48 Million0.71% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.08MShares$42 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.82MShares$39.9 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.45MShares$36.9 Million0.63% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $554M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...